When was TECHLAB founded?

TECHLAB was founded in 1989 and raised its 1st funding round 15 years after it was founded.

Where is TECHLAB located?

TECHLAB is headquartered in United States. It is registered at Blacksburg, Virginia.

Which legal entities is TECHLAB associated with?

TECHLAB is associated with TechLab and 1 other.

How many employees does TECHLAB have?

As of Mar 31, 2026, the latest employee count at TECHLAB is 154.

Is TECHLAB a funded company?

TECHLAB is a funded company, having raised an undisclosed amount across 10 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jun 01, 2004.

When was the latest funding round of TECHLAB?

TECHLAB's latest funding was a $***** Grant (prize money) round on May 25, 2014, with participation from 1 investor.

Where does TECHLAB rank among its competitors?

TECHLAB ranks 10th amongst 31 active competitors, of which 5 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was Functional Gut Group, which secured $7.45M in Apr, 2025.

Who are the top competitors of TECHLAB?

TECHLAB's top competitors include Prometheus Laboratories, Viome Life Sciences and NinePoint Medical. Among them, Functional Gut Group secured the most recent funding round in April, 2025.

TECHLAB - 2026 Company Profile, Funding & Competitors

TECHLAB is an acquired company based in United States, founded in 1989. It operates as an Infectious disease diagnostics developer and manufacturer, improving intestinal disease diagnosis. TECHLAB has raised an undisclosed amount in funding. The company has 31 active competitors, including 5 funded and 6 that have exited. Its top competitors include companies like Prometheus Laboratories, Viome Life Sciences and NinePoint Medical.

Company Details

Infectious disease diagnostics developer and manufacturer, improving intestinal disease diagnosis. They specialize in creating in vitro diagnostic products for a range of intestinal diseases. Their offerings include diagnostics for *C. difficile*, respiratory pathogens, fecal leukocyte screening, intestinal inflammation, *H. pylori*, parasites, foodborne pathogens, and *C. perfringens*. They provide contract manufacturing and research services, leveraging their expertise in diagnostics development. They focus on innovation and quality, aiming to bring cutting-edge products to market. Their team includes professionals with expertise in regulatory affairs, quality control, manufacturing, and research and development. They collaborate with universities and researchers globally to advance diagnostic capabilities.

Website: www.techlab.com/
Email ID: *****@techlab.com
Registered Address: Blacksburg, Virginia

Key Metrics

Founded Year

1989

Location

United States

Stage

Acquired

Latest Funding Round

Grant (prize money), May 25, 2014, $*****

Investors

HHS

Ranked

10^th among 31 active competitors

Employee Count

154 as on Mar 31, 2026

Similar Companies

Prometheus Laboratories & 39 more

Exit Details

Acquired by SSI Diagnostica (Aug 22, 2022)

View TECHLAB's full profile

TECHLAB is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
TECHLAB, INC. CIN: 541527427 , United States, Active	Dec 26, 999	-	146 (As on Dec 31, 2024)	-
TechLab CIN: 40103800330 , Latvia, Active	Jun 17, 2014	$117K (As on Dec 31, 2024)	1 (As on Dec 31, 2022)	-

TECHLAB got acquired by SSI Diagnostica on Aug 22, 2022. It was facilitated by Lincoln International and Gibson Dunn.

Click here to take a look at TECHLAB's acquisition in detail

TECHLAB has raised funding over 10 rounds. Its first funding round was on Jun 01, 2004. Its latest funding round was a Grant (prize money) round on May 25, 2014 for $*****. 1 investor participated in its latest round. TECHLAB has 1 institutional investor.

Here is the list of recent funding rounds of TECHLAB:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 25, 2014	2171915	Grant (prize money)	4114814	8373499	7668436	8406378
Jun 05, 2012	5462361	Grant (prize money)	8304204	5803720	8839235	HHS
Jun 04, 2012	2421387	Grant (prize money)	7285842	7112074	6671862	HHS

Access funding benchmarks and valuations. Sign up today!

View details of TECHLAB's funding rounds and investors

TECHLAB's employee count trend

TECHLAB has 154 employees as of Mar 26. Here is TECHLAB's employee count trend over the years:

Uncover TECHLAB's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of TECHLAB include Prometheus Laboratories, Viome Life Sciences and NinePoint Medical. Here is the list of Top 10 competitors of TECHLAB, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Prometheus Laboratories 1995, San Diego (United States), Acquired	Diagnostics and therapeutics for personalized medicine	-	Avista Capital Partners, Pamlico Capital & 3 others	63/100
2nd	Viome Life Sciences 2016, Bothell (United States), Series C	Provider of tests to prevent, treat, and cure chronic diseases, and cancer	$92.4M	BOLD Capital Group, Khosla Ventures & 4 others	62/100
3rd	NinePoint Medical 2008, Bedford (United States), Series C	Advanced medical imaging for real-time tissue microstructure visualization and analysis	$98.3M	Prospect Venture Partners, Corning & 4 others	48/100
4th	InDex Pharmaceuticals 2000, Stockholm (Sweden), Public	DNA-based immunomodulatory sequence medication for the treatment of inflammtatory bowel disease.	$45.4M	Vinnova, Industrifonden & 5 others	46/100
5th	Functional Gut Group 2014, Manchester (United Kingdom), Acquired	Developer of a diagnostic test for gut health	$7.45M	Foresight Group	44/100
6th	G-Tech Medical 2010, Mountain View (United States), Series A	Wireless GI diagnostics improving gastrointestinal disorder treatment through advanced technology	$6.93M	NetScientific, Breakout Labs & 3 others	37/100
7th	EnteraSense 2016, Galway (Ireland), Seed	Ingestible biosensor for GI disease	$1.14M	NDRC, European Commission & 1 others	34/100
8th	Given Imaging 1998, Minneapolis (United States), Acquired	Global healthcare technology company alleviating pain, restoring health, extending life	-	Elron Ventures, Genesis Capital	33/100
9th	sclero-smart 2018, United States, Unfunded	Developer of blood test for detecting systemic sclerosis and scleroderma	-	-	32/100
10th	TECHLAB 1989, United States, Acquired	Infectious disease diagnostics developer and manufacturer, improving intestinal disease diagnosis	-	HHS	34/100